← All stocks

Apimeds Pharmaceuticals US, Inc.

APUS No buying or selling
CIK 0001894525 #5370 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

4 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Inscobee Inc. entity
10% owner
6,416,365
$11.93M
+14.2%
Emerson Erik C.
Chief Executive Officer
750,000
$1.40M
Koo Jakap
Director
643,885
$1.20M
+4.6%
Kim Christopher
Chairman and CMO
277,500
$516.15K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 May 2025